Description

EGLUZIN is an SGLT2 inhibitor used in the management of type 2 diabetes mellitus. It works by helping the kidneys remove excess glucose through urine, thereby lowering blood sugar levels. Empagliflozin also has established cardiovascular and kidney benefits in appropriate patients, as prescribed by a healthcare professional.